Biosynthesis of heparin. III. Formation of iduronic acid residues (original) (raw)

Structural evidence for leucine at the reactive site of heparin cofactor II

Frank Church

Biochemistry, 1985

View PDFchevron_right

Non-Anticoagulant Heparins as Heparanase Inhibitors

giuseppe cassinelli

Advances in Experimental Medicine and Biology, 2020

View PDFchevron_right

Immobilization Alters Heparin Cleaving Properties of Heparinase I

Indu Bhushan

Glycobiology, 2017

View PDFchevron_right

The Solution Structure of Heparan Sulfate Differs from That of Heparin

Elizabeth Rodriguez

Journal of Biological Chemistry, 2013

View PDFchevron_right

Synthesis and Hemolytic Activity of Some Hederagenin Diglycosides

Laurence Voutquenne

CHEMICAL & PHARMACEUTICAL BULLETIN, 2004

View PDFchevron_right

Changes in the USP Heparin Monograph and Implications for Clinicians

maureen smythe

Pharmacotherapy, 2010

View PDFchevron_right

ChemInform Abstract: Peptide Synthesis

Michael Verlander

ChemInform, 2008

View PDFchevron_right

Generic Low Molecular Weight Heparins: A Significant Dilemma

Shaker Mousa

Clinical and Applied Thrombosis/Hemostasis, 2005

View PDFchevron_right

Challenges for Heparin Production: Artificial Synthesis or Alternative Natural Sources?

Paulo Mourao

Glycobiology Insights, 2012

View PDFchevron_right

Enhancement of Heparin Cofactor II Anticoagulant Activity

Frank Church

Journal of Biological Chemistry, 1999

View PDFchevron_right

The Putative Heparin-specific N-Acetylglucosaminyl N-Deacetylase/N-Sulfotransferase Also Occurs in Non-heparin-producing Cells

Leny Toma

Journal of Biological Chemistry, 1998

View PDFchevron_right

Arginine 25 and Arginine 28 of lactoferrin are critical for effective heparin neutralization in blood

Frank Church

Archives of Biochemistry and Biophysics, 2003

View PDFchevron_right

Biosynthesis of heparin: Availability of glucosaminyl 3-O-sulfation sites

Giangiacomo Torri

Journal of Biological Chemistry

View PDFchevron_right

Synthesis of Uridine 5′-diphosphoiduronic Acid: A Potential Substrate for the Chemoenzymatic Synthesis of Heparin

Michel Weïwer, Robert Linhardt

The Journal of Organic Chemistry, 2008

View PDFchevron_right

Identification and Characterization of Heparin/Heparan Sulfate Binding Domains of the Endoglycosidase Heparanase

Israel Vlodavsky

Journal of Biological Chemistry, 2005

View PDFchevron_right

Preactivation-Based, One-Pot Combinatorial Synthesis of Heparin-like Hexasaccharides for the Analysis of Heparin-Protein Interactions

Steven Dulaney

Chemistry - A European Journal, 2010

View PDFchevron_right

The Multiple Faces of Heparin: Opportunities in COVID-19 Infection and Beyond

Job Harenberg

Thrombosis and Haemostasis, 2020

View PDFchevron_right

Heparin from bovine intestinal mucosa: Glycans with multiple sulfation patterns and anticoagulant effects

Paulo Mourao

Thrombosis and Haemostasis, 2012

View PDFchevron_right

Heparin and heparan sulphate protect basic fibroblast growth factor from non-enzymic glycosylation

Ashok Singh

Biochemical Journal, 1999

View PDFchevron_right

Contaminated Heparin Associated with Adverse Clinic Events and Activation of the Contact System

Moheb Nasr

Journal of Vascular Surgery, 2008

View PDFchevron_right

Heparin prevents programmed cell death in human trophoblast

lesley regan

Molecular Human Reproduction, 2006

View PDFchevron_right

Metabolic engineering of Chinese hamster ovary cells: Towards a bioengineered heparin

Susan Sharfstein

Metabolic Engineering, 2012

View PDFchevron_right

Biosynthesis of dermatan sulfate. I. Formation of L-iduronic acid residues

L.-a. Fransson

The Journal of biological chemistry, 1975

View PDFchevron_right

Quantitation of heparosan with heparin lyase III and spectrophotometry

Fuming Zhang

Analytical Biochemistry, 2014

View PDFchevron_right

Heparin: Past, Present, and Future

Susan Sharfstein

Pharmaceuticals, 2016

View PDFchevron_right